Motivation: Interest in mid-field cardiovascular magnetic resonance (CMR) has grown and may offer increased accessibility and novel applications. However, demonstrations of clinical use of 0.55T CMR exams are still lacking. Goal(s): To demonstrate clinical feasibility, we present early use of 0.55T CMR for characterization of patients with known/suspected cardiomyopathy. Approach: Patients with known/suspected cardiomyopathies underwent 0.55T scans, using cine imaging, parametric mapping, and late gadolinium enhancement and compared to clinical 1.5T exams and clinical information. Results: In 23 patients, 0.55T CMR accurately differentiated etiologies of cardiomyopathy (amyloidosis, ischemic, non-ischemic, recent inflammatory event, no cardiomyopathy). Clinical interpretation was consistent with 1.5T results and clinical data. Impact: Cardiomyopathies comprise >20% of clinical referrals to CMR, and phenotyping uses multiple pulse sequences pre- and post-contrast. This patient population is high priority for assessment by 0.55T. Our results indicate accurate clinical interpretation of 0.55T CMR for patients with cardiomyopathies.
Bandettini et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: